Stocksigma LogoStocksigma Logo

Biocon Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 43,889 (+2.2% YoY | +1.2% QoQ) ■ EBITDA: 8,309 (-0.5% YoY | -1.9% QoQ) ■ EBITDA Margin (%): 18.9 (-52 bps YoY | -61 bps QoQ) ■ PAT: 413 (-51.1%

Biocon Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Biocon Ltd · Financial Result · 04 Nov 2026, 6:48 pm

Biocon Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 43,889 (+2.2% YoY | +1.2% QoQ) ■ EBITDA: 8,309 (-0.5% YoY | -1.9% QoQ) ■ EBITDA Margin (%): 18.9 (-52 bps YoY | -61 bps QoQ) ■ PAT: 413 (-51.1% YoY | -70.7% QoQ) ■ EPS (INR): 0.25 (-61.5% YoY | -71.3% QoQ) Biocon Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Biopharmaceuticals - Biosimilars ■ Revenue: 28,086 (+3.2% YoY | -1.6% QoQ) ■ EBIT: 325 (-80.6% YoY | -81.0% QoQ) ■ EBIT Margin (%): 1.2 (-499 bps YoY | -485 bps QoQ) Biopharmaceuticals - Generics ■ Revenue: 7,744 (+10.4% YoY | +1.9% QoQ) ■ EBIT: -304 (+56.1% YoY | +1.6% QoQ) ■ EBIT Margin (%): -3.9 (+594 bps YoY | +14 bps QoQ) Services ■ Revenue: 8,327 (-8.6% YoY | +13.1% QoQ) ■ EBIT: 537 (-37.0% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 6.4 (-291 bps YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Biocon Ltd

All Biocon Ltd announcements